AU2000265672A1 - Somatic cloning gene transfer for the production of recombinant proteins, cells and organs - Google Patents

Somatic cloning gene transfer for the production of recombinant proteins, cells and organs

Info

Publication number
AU2000265672A1
AU2000265672A1 AU2000265672A AU6567200A AU2000265672A1 AU 2000265672 A1 AU2000265672 A1 AU 2000265672A1 AU 2000265672 A AU2000265672 A AU 2000265672A AU 6567200 A AU6567200 A AU 6567200A AU 2000265672 A1 AU2000265672 A1 AU 2000265672A1
Authority
AU
Australia
Prior art keywords
organs
cells
production
gene transfer
recombinant proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2000265672A
Inventor
Gottfried Brem
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Apogene GmbH and Co KG
Original Assignee
Apogene GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apogene GmbH and Co KG filed Critical Apogene GmbH and Co KG
Publication of AU2000265672A1 publication Critical patent/AU2000265672A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0271—Chimeric animals, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/101—Bovine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
AU2000265672A 2000-07-27 2000-07-27 Somatic cloning gene transfer for the production of recombinant proteins, cells and organs Abandoned AU2000265672A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2000/007239 WO2002009507A1 (en) 2000-07-27 2000-07-27 Somatic cloning gene transfer for the production of recombinant proteins, cells and organs

Publications (1)

Publication Number Publication Date
AU2000265672A1 true AU2000265672A1 (en) 2002-02-13

Family

ID=8164039

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2000265672A Abandoned AU2000265672A1 (en) 2000-07-27 2000-07-27 Somatic cloning gene transfer for the production of recombinant proteins, cells and organs

Country Status (6)

Country Link
US (1) US8030537B1 (en)
EP (1) EP1303183A1 (en)
JP (1) JP2004518405A (en)
AU (1) AU2000265672A1 (en)
CA (1) CA2416877C (en)
WO (1) WO2002009507A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1395669B1 (en) 2001-01-26 2009-07-22 Selexis S.A. Matrix attachment regions and methods for use thereof
SE0300207D0 (en) 2003-01-29 2003-01-29 Karolinska Innovations Ab New use and composition
IN2014DN02483A (en) 2003-10-24 2015-05-15 Selexis Sa

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4000939A1 (en) 1990-01-15 1991-07-18 Brem Gottfried Prof Dr Dr METHOD FOR OBTAINING ANTIBODIES
US5811635A (en) * 1992-08-03 1998-09-22 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Chimeric mouse for human and mouse immune systems
US6018096A (en) * 1993-05-03 2000-01-25 Surrogen, Inc. Animal model for engraftment, proliferation and differentiation of human hematopoietic stem cells
ATE221382T1 (en) * 1993-05-24 2002-08-15 Ximerex Inc THE GENERATION OF TOLERANCE AGAINST FOREIGN TRANSPLANTS THROUGH TOLEROGENESIS WITH THE HELP OF SUBSTITUTE LIVING BEINGS
WO1996039811A1 (en) * 1995-06-07 1996-12-19 Novartis Ag Immunocompromised animals comprising human synovial tissue
US5945577A (en) * 1997-01-10 1999-08-31 University Of Massachusetts As Represented By Its Amherst Campus Cloning using donor nuclei from proliferating somatic cells
GB9703550D0 (en) 1997-02-20 1997-04-09 Ppl Therapeutics Scotland Ltd Cell mediated transgenesis
DE19726597C1 (en) * 1997-06-23 1998-11-19 Wengler Georg S Preparation of human monoclonal antibodies
WO1999009141A1 (en) 1997-08-14 1999-02-25 Biotransplant, Inc. Porcine totipotent cells and method for long-term culture
DE59812083D1 (en) * 1998-01-16 2004-11-11 Agrobiogen Gmbh EFFICIENT CORE TRANSFER WITH FETAL FIBROBLASTS
CA2318117A1 (en) * 1998-01-16 1999-07-22 Agrobiogen Gmbh Efficient nuclear transfer using primordial germ cells
AU1462200A (en) * 1998-11-02 2000-05-22 Gtc Biotherapeutics, Inc. Transgenic and cloned mammals

Also Published As

Publication number Publication date
CA2416877A1 (en) 2003-01-22
WO2002009507A1 (en) 2002-02-07
US8030537B1 (en) 2011-10-04
EP1303183A1 (en) 2003-04-23
CA2416877C (en) 2013-03-12
JP2004518405A (en) 2004-06-24

Similar Documents

Publication Publication Date Title
AU2001269923A1 (en) Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
WO2002006457A3 (en) Novel lipase genes
AU2002232819A1 (en) Methods for the production of multimeric proteins, and related compositions
HK1045326A1 (en) Microbial beta-glucuronidase genes, gene products and uses thereof
AU2839401A (en) Enzymes and genes used for producing vanillin
AU2000265672A1 (en) Somatic cloning gene transfer for the production of recombinant proteins, cells and organs
AU2001247467A1 (en) Peptides targeting specifically tumor-derived endothelial cells
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
AU4008500A (en) Platelet-derived growth factor related gene and protein
EP1148139A4 (en) Variant luciferase, variant luciferase gene, novel recombinant dna and process for producing variant luciferase
HK1052029A1 (en) Method for increasing the yield of recombinant proteins in microbial fermentation processes.
WO2001064912A3 (en) Triazine degrading enzymes
AU4771600A (en) Cells, culture methods and their uses
AU2002334950A1 (en) T. reesei phytase enzymes, polynucleides encoding the enzymes, vectors and host cells thereof, and methods of using
AU2002306218A1 (en) Saponin-digesting enzymes, genes thereof and soyasapogenol B mass production system
WO2000053759A8 (en) Expression of human alpha-fetoprotein in mammalian cells
AU2001259240A1 (en) Novel stmst protein and nucleic acid mocecules and uses therefor
EP1403373A4 (en) Saponin-digesting enzymes, genes thereof and soyasapogenol b mass production system
AU5034200A (en) Oxidoreductase proteins
AU5780999A (en) Genes that regulate hematopoietic blood forming stem cells and uses thereof
AU4203400A (en) Plant viral movement protein genes
AU6181500A (en) Gene encoding novel tsp1-like protein
AU2002350599A1 (en) Homeotic genes and proteins, and uses thereof
AU2001234150A1 (en) Novel protein and gene encoding the same
AU6728601A (en) A novel polypeptide, a human k-ras gene protein 36 and the polynucleotide